Company intelligence / Profile preview
Kaigene, Inc.
Rockville, MD, United Stateskaigene.us ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Kaigene is a biotechnology start-up founded in 2022 and based in Rockville/North Bethesda, Maryland. The company focuses on the discovery and development of innovative therapeutic antibodies and fusion proteins to address significant unmet needs in autoimmune diseases. Its core team has industry experience in biologics discovery and development. The company appears to be at the preclinical or IND-enabling stage with no disclosed clinical results yet.[1][2][3][5]
- Therapeutic areas
- Immunology
- Modalities
- Therapeutic antibodiesFusion proteins[4][2]
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Kaigene, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kaigene, Inc..